Physical branch meetings are currently cancelled due to COVID-19. However there are virtual activities being run by some branches. Please contact your local branch for more information.

We hope you find the information on these pages helpful. Our team is working tirelessly to provide up to date advice in relation to the COVID-19/Coronavirus pandemic. Record numbers of people are now turning to NASS for support, and we hope to be here for everyone. Our helpline and advice service are only possible thanks to donations from people like you.

If you are able to make a donation to NASS today, we'd be so grateful.



New biologic on the horizon

Izana Bioscience, a new UK based pharmaceutical company, is running a phase 2 clinical trial for 42 patients across 10 centres in the UK for its new drug,  Namilumab.

Britain leaving European Union

A no-deal Brexit?

NASS has been asked a few times recently about a no-deal Brexit and the impact that this may have on the supply of medicines to the UK.

NICE logo

NICE launch Quality Standard for Spondyloarthritis

NASS welcomes the publication today by NICE of a set of Quality Standards for Spondyloarthritis. Now we need to ensure that they are implemented effectively across the country so that every AS patient, every time, gets early diagnosis and high quality care.

Scan of Poppy's article

Poppy’s story

Many thanks to NASS Trustee Poppy, who has helped to raise awareness of the terrible impact living with AS can have on people's lives by sharing her family's story with Choice Magazine.